Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva ...

AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board of directors as the link between the ...

The Biotechnology Innovation Organization (BIO) has started the nationwide “​The Fight of Our Lives” campaign, creating a ...

Astellas will close a stem cell therapy site. GSK is pushing a Hansoh Pharma-partnered ADC into multiple phase 3 trials. | ...

Actress, producer, and artist Lucy Liu has joined Pfizer’s mission to deliver a knockout blow against cancer, becoming the ...

Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...

Viatris and Teva Pharmaceutical Industries recently launched separate recalls in the U.S. related to dissolution problems for ...

Apart from Daiichi, a growing number of drugmakers have elected to part ways with their over-the-counter businesses in recent ...

The FDA should strengthen the evidence required for the approval of drugs under its accelerated pathway and increase the ...

The results seen with Foundayo, also known as orforglipron, enabled Lilly’s late-stage Achieve-4 study to hit its primary ...

Monday’s FDA approval makes Filspari the first therapy specifically indicated for FSGS, a condition that represents a $1 ...

Omnicom Health has stamped its mark on the recently acquired FCB Health New York, rebranding the ad agency as Olixir New York ...